220 related articles for article (PubMed ID: 19693649)
21. Vanillin improves and prevents trinitrobenzene sulfonic acid-induced colitis in mice.
Wu SL; Chen JC; Li CC; Lo HY; Ho TY; Hsiang CY
J Pharmacol Exp Ther; 2009 Aug; 330(2):370-6. PubMed ID: 19423842
[TBL] [Abstract][Full Text] [Related]
22. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation.
Obermeier F; Dunger N; Strauch UG; Hofmann C; Bleich A; Grunwald N; Hedrich HJ; Aschenbrenner E; Schlegelberger B; Rogler G; Schölmerich J; Falk W
Gastroenterology; 2005 Sep; 129(3):913-27. PubMed ID: 16143131
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye.
Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC
Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668
[TBL] [Abstract][Full Text] [Related]
24. Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis.
Dayer Schneider J; Seibold I; Saxer-Sekulic N; Paredes BE; Saurer L; Mueller C
Eur J Immunol; 2009 Jul; 39(7):1743-53. PubMed ID: 19551899
[TBL] [Abstract][Full Text] [Related]
25. IL-10 gene therapy prevents TNBS-induced colitis.
Lindsay J; Van Montfrans C; Brennan F; Van Deventer S; Drillenburg P; Hodgson H; Te Velde A; Sol Rodriguez Pena M
Gene Ther; 2002 Dec; 9(24):1715-21. PubMed ID: 12457286
[TBL] [Abstract][Full Text] [Related]
26. IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.
Tomita T; Kanai T; Totsuka T; Nemoto Y; Okamoto R; Tsuchiya K; Sakamoto N; Ohteki T; Hibi T; Watanabe M
Eur J Immunol; 2009 Oct; 39(10):2737-47. PubMed ID: 19637223
[TBL] [Abstract][Full Text] [Related]
27. Blockade of CXCL12/CXCR4 axis ameliorates murine experimental colitis.
Mikami S; Nakase H; Yamamoto S; Takeda Y; Yoshino T; Kasahara K; Ueno S; Uza N; Oishi S; Fujii N; Nagasawa T; Chiba T
J Pharmacol Exp Ther; 2008 Nov; 327(2):383-92. PubMed ID: 18716065
[TBL] [Abstract][Full Text] [Related]
28. Pancreatic changes in TNBS-induced colitis in mice.
Barthet M; Dubucquoy L; Garcia S; Gasmi M; Desreumaux P; Colombel JF; Grimaud JC; Iovanna J; Dagorn JC
Gastroenterol Clin Biol; 2003 Oct; 27(10):895-900. PubMed ID: 14631304
[TBL] [Abstract][Full Text] [Related]
29. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
[TBL] [Abstract][Full Text] [Related]
30. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
[TBL] [Abstract][Full Text] [Related]
31. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
[TBL] [Abstract][Full Text] [Related]
32. IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis.
Fichtner-Feigl S; Young CA; Kitani A; Geissler EK; Schlitt HJ; Strober W
Gastroenterology; 2008 Dec; 135(6):2003-13, 2013.e1-7. PubMed ID: 18938165
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2.
Ivory CP; Wallace LE; McCafferty DM; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2008 Dec; 295(6):G1202-10. PubMed ID: 18845573
[TBL] [Abstract][Full Text] [Related]
34. Role of innate lymphoid cells in chronic colitis during anti-IL-17A therapy.
Park CH; Lee AR; Ahn SB; Eun CS; Han DS
Sci Rep; 2020 Jan; 10(1):297. PubMed ID: 31941937
[TBL] [Abstract][Full Text] [Related]
35. The bile acid receptor FXR is a modulator of intestinal innate immunity.
Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
[TBL] [Abstract][Full Text] [Related]
36. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions.
Liu BG; Jia XM; Cao YY; Chen SH; Gao PH; Wang Y; Jiang YY; Cao YB
J Ethnopharmacol; 2008 Jan; 115(1):1-8. PubMed ID: 17964746
[TBL] [Abstract][Full Text] [Related]
37. IL-17/IFN-γ interactions regulate intestinal inflammation in TNBS-induced acute colitis.
Jin Y; Lin Y; Lin L; Zheng C
J Interferon Cytokine Res; 2012 Nov; 32(11):548-56. PubMed ID: 23030668
[TBL] [Abstract][Full Text] [Related]
38. Proinflammatory properties of IL-4 in the intestinal microenvironment.
Van Kampen C; Gauldie J; Collins SM
Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G111-7. PubMed ID: 15591585
[TBL] [Abstract][Full Text] [Related]
39. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.
Song J; Matsuda C; Kai Y; Nishida T; Nakajima K; Mizushima T; Kinoshita M; Yasue T; Sawa Y; Ito T
J Pharmacol Exp Ther; 2008 Jan; 324(1):276-83. PubMed ID: 17898319
[TBL] [Abstract][Full Text] [Related]
40. Acute and chronic responses associated with adrenomedullin administration in experimental colitis.
Talero E; Sánchez-Fidalgo S; de la Lastra CA; Illanes M; Calvo JR; Motilva V
Peptides; 2008 Nov; 29(11):2001-12. PubMed ID: 18708104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
